LabCorp
Margery Connelly, PhD, MBA, currently serves as Strategic Director for Diagnostics R&D at Laboratory Corporation of America Holdings and previously held the position of Vice President of Translational Research at LipoScience. Margery's career includes leadership roles at Janssen Pharmaceutical Companies of Johnson and Johnson, such as Team Leader for Target ID and Validation and Head of Cellular and Biochemical Pharmacology in CVM Discovery. Additionally, Margery worked as a Research Assistant Professor in the Department of Pharmacological Sciences at Stony Brook University. Margery earned an MBA in Pharmaceutical Management from Drexel University's LeBow College of Business and holds a B.S. in Biochemistry from Stony Brook University.
This person is not in any teams
This person is not in any offices
LabCorp
78 followers
Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. Before a merger with National Health Laboratory in 1995, the company operated under the name Roche BioMedical. LabCorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina, where the company is headquartered.